Singapore Health Sciences Authority Cracks Down on E-Cigarette Black Market

Jul.05.2024
Singapore Health Sciences Authority Cracks Down on E-Cigarette Black Market
Singapore Health Sciences Authority (HSA) seized over 350,000 e-cigarette products worth $6 million in June raids.

According to Channel News Asia's report on July 4th, the Health Sciences Authority (HSA) in Singapore stated that over 350,000 e-cigarette products were seized in raids across the country in June.


The black market value of these e-cigarette products exceeds 6 million Singapore dollars (approximately 4.44 million US dollars) and were originally planned to be sold through Telegram.


The Health Sciences Authority (HSA) confirmed that a series of raids carried out from June 14 to 18 at three separate locations effectively targeted one of Singapore's largest e-cigarette distribution networks.


Authorities received news on June 14 that a large quantity of e-cigarettes and components were found in a warehouse at Woodlands Loop.


Following that, there were two more raids conducted, one at an apartment unit on Guillemard Crescent on the same day, and another at a warehouse unit in the Woodlands industrial park on June 18th. HSA stated that more e-cigarette products were also found at these two locations.


Additionally, 14 e-cigarettes suspected to contain the controlled substance tetrahydrocannabinol (THC) have been discovered, and these products have been handed over to the Central Narcotics Bureau (CNB) for processing. Four men and women, ranging in age from 34 to 52, are currently assisting in the investigations conducted by the Health Sciences Authority (HSA) and CNB.


The Health Sciences Authority (HSA) has reported seizures of e-cigarette products worth over 18 million Singapore dollars (13.32 million US dollars) since January. Authorities have warned that importing, distributing, selling, or advertising e-cigarette products is illegal.


For the first time offenders found importing, distributing, or selling e-cigarette products, they can be fined up to $10,000 (USD 7401), or face imprisonment for a maximum of 6 months, or both. For second-time offenders and beyond, the maximum fine can reach $20,000 (USD 14,802), or imprisonment for up to 12 months, or both. It is illegal to purchase, use, or possess e-cigarettes, with a maximum fine of $2000 (USD 1480).


Last year, Singapore authorities dealt with around 8,000 cases of e-cigarette-related offenses, a 43% increase from the 5,600 cases in 2022. There were a total of 7,600 recorded offenses in 2021.


In December of last year, authorities announced plans to enhance inspections of e-cigarettes and their components at border checkpoints in Singapore. They also stated that they would increase efforts to combat the use of e-cigarettes in "public hotspots.


From January 1 to March 31, it was discovered that over 2200 people were using or in possession of e-cigarettes.


In May this year, Rahayu Mahzam, the Senior Parliamentary Secretary of the Ministry of Health, stated that the Health Sciences Authority is reviewing legal penalties to enhance deterrence against e-cigarette advertising, importation, and distribution.


She added that the Health and Safety Authority has been monitoring illegal e-cigarette sales on social media, e-commerce, and communication platforms, and taking action to remove e-cigarette-related content.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22